Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Compounded semaglutide( Ozempic and Wegovy) and compounded tirzepatide (Zepbound and Mounjaro) are GLP-1 medications
However, patients with established cardiovascular disease, particularly those with heart failure or arrhythmias, may benefit from more structured monitoring
The company's stock has fallen 41% since closing at $66 per share on Thursday after the Food and Drug Administration (FDA) on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and Wegovy, is no longer in short supply
Dosing: Weekly subcutaneous injection Maximum dose: 15 mg/week Average weight loss (SURMOUNT-1): 20% over 72 weeks at the highest dose List price: ~$1,086/mo Self-pay: From $399/mo via LillyDirect FDA-approved for: Adults with BMI 30 (or 27 with comorbidities) Side-by-Side Comparison Side Effects: Similar, but Worth Reading Both medications have GLP-1-class side effects: nausea, diarrhea, vomiting, constipation, abdominal pain
US$ 22.15
US$ 28.75
US$ 27.97
US$ 24.64
US$ 27.01
US$ 27.43
US$ 29.39
US$ 25.41
